Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Https://www.telegraph.co.uk/business/2023/12/23/scramble-uranium-supplies-new-nuclear-silk-road/
Looks like we could come up smelling of roses
Profit taking due to the share price rise is understandable given the rise but this is still under valued.
Loss this quarter is less than projected.
Cash was £35m, unlike to change a great deal. MC still only £54m.
That's a lot of company for £19m
Positive result in every hole
Pictures of the drill core on twitter. looks good
https://x.com/MarcFCMetals/status/1734125731209207895?s=20
But come on it's not 6 months ago.
Money is getting a bit easier to get.
Ok why is this so bad it warrants a drop on 40% to historic lows?
The potential here is huge.
Surface shows
A company 10km away is building a processing plant.
This could be a mine in a very short space of time
And at a very low Capx
These guys don't hang about.
Drilling has started.
Only shallow as the stuff is showing at ground level.
The raise puts us in a stronger position because they raised the cash so quickly and easily.
It would not surprise me if when talking to big pharma they said we'll you only have cash for a year, you need a deal we want a discount.
That's gone.
Did anyone notice JMC said pharma wanted 30 patients?
Deal could be sooner than expected
All very positive.
New starts are very bright, young and very enthusiastic. All the team spoke very highly.
Dr Mandeep has been there 3 months. lets give her a chance.
SCIB 1
the intresting thing was the up lift for 9 out of 11 to 11 out of 13 did not include patient 2 (24% reduction) they have not been rescaned as yet. If they do shrink tumour to more then 30% ORR would be 92%
Inital delay in recrutment was due to trying to use only patients on a single CPI. this is no longer standard care.
Modi 1
ongoing with good recrutment.
As a monotherapy ORR of about 60%. similar to SCIB1
With double CPI should again be similar to SCIB 1
will concentrate on cancers with aproved CPI treatments
Deals could come at any time for Glymab at any time.
Enough cash there till meaning full results in
Great chat with the lads at Mines and money today
They are very positive
Looking forward to getting a rig onsite
If they do a fund raise so what. The last was at a small discount to the SP at the time.
Money will be needed to advance current projects.
Near term results could prove a major inflection point and provide the SP a proper re-rate
SCIB 1
At least 6 patients will have had a further scan.
There could be a further 6 patients who have had the week 13 scan.
Further details on the response rates between Cohort 1 and 2.
If Cohort 2 is at 80+‰ this will be huge as the combination of CPI ,I believe, results in worse side effects.
As it's open label we can have an update at any time.